Biohit Oyj - Company Announcement

BIOHIT BEGINS CO-DETERMINATION NEGOTIATIONS WITH PERSONNEL IN FINLAND

In order to improve profitability, Biohit Oyj has today decided to begin        
negotiations with company personnel in accordance with the Co-operation         
Act. As stated in the interim report published on 3 August 2007, the      
Biohit Group's second-quarter net sales did not meet the company's expectations,
and the company's full-year result is forecast to remain below the level of the 
previous year. The result was weakened by more moderate than expected           
development in net sales in Asian markets, as well as increased fixed costs and 
financing expenses.                                                             

Biohit is aiming to improve the Group's profitability during the remainder of   
the year by intensifying sales and marketing, and lightening its cost structure 
with regard to fixed costs. The company today decided to launch
co-determination negotiations. A maximum of 22 employees will be affected,
primarily those in Helsinki and in the diagnostics business, whose operating
result is still in the red. According to the preliminary plan, savings on
personnel costs would be made through lay-offs lasting until further notice,
which would begin this year. 

Biohit Oyj                                                                      
Osmo Suovaniemi                                                                 
President & CEO                                                                 


Further information:                                                            
Osmo Suovaniemi, M.D., Ph.D., Professor                                         
President & CEO                                                                 
Tel: +358-9-773 861                                                             
Mobile: +358-40-745 5605                                                        
Email: osmo.suovaniemi@biohit.com                                               

Distribution:                                                                   
Helsinki Exchanges                                                              
Financial Supervisory Authority                                                 
Press                                                                           
http://www.biohit.com